CryoTherapeutics Overview
- Year Founded
-
2009
- Status
-
Private
- Employees
-
12
- Latest Deal Type
-
Later Stage VC
- (Upcoming)
- Latest Deal Amount
-
$11.1M
- Investors
-
13
CryoTherapeutics General Information
Description
Developer of a cryotherapy system designed to offer treatment for coronary artery diseases. The company's system offers a novel catheter system, which utilizes cryo energy to treat and prevent heart attacks and focuses on the development, demonstration of clinical benefit, and early-stage commercialization of a proprietary cryotherapy system in order to prevent heart attacks, enabling heart surgeons to ensure safety and efficacy of cryo energy in the cardiovascular system and extend the benefits of cryo energy to the problem of diseased coronary arteries.
Contact Information
Website
www.cryotherapeutics.comCorporate Office
- Rue Alfred Deponthière 48
- 4431 Loncin
- Belgium
Corporate Office
- Rue Alfred Deponthière 48
- 4431 Loncin
- Belgium
CryoTherapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 13. Later Stage VC | $11.1M | Upcoming | ||||
| 12. Later Stage VC (Series B) | 02-Apr-2024 | Completed | Clinical Trials - General | |||
| 11. Later Stage VC | 17-Feb-2022 | Completed | Clinical Trials - General | |||
| 10. Later Stage VC (Series B) | 30-Dec-2021 | Completed | Generating Revenue | |||
| 9. Grant | 24-Jun-2021 | Completed | Clinical Trials - Phase 1 | |||
| 8. Later Stage VC (Series B) | 27-Jun-2019 | Completed | Clinical Trials - Phase 1 | |||
| 7. Later Stage VC (Series B3) | 12-Apr-2019 | Completed | Generating Revenue | |||
| 6. Grant | 12-Apr-2019 | Completed | Pre-Clinical Trials | |||
| 5. Later Stage VC (Series B2) | 06-Dec-2017 | $1.99M | $19.8M | Completed | Clinical Trials - Phase 1 | |
| 4. Later Stage VC (Series B1) | 22-Jul-2016 | $537K | $17.8M | Completed | Generating Revenue |
CryoTherapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| B-5 Shares | ||||||||
| B-4 Shares | ||||||||
| B-3 Shares | ||||||||
| B-2 Shares | ||||||||
| B-1 Shares | ||||||||
| B Shares | ||||||||
| A Shares | 114,455 | $1.086988 | $86.24 | $86.24 | 1x | $86.24 | 28.88% | |
| Ordinary Shares | 30,489 | $1.086988 | $86.24 | $86.24 | 1x | $86.24 | 7.69% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
CryoTherapeutics Comparisons
Industry
Financing
Details
CryoTherapeutics Competitors (4)
One of CryoTherapeutics’s 4 competitors is Vygon (uk) Ltd., a Corporation company based in Hilton Head Island, SC.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Vygon (uk) Ltd. | Corporation | Hilton Head Island, SC | ||||
| Tactile Medical | Formerly VC-backed | Minneapolis, MN | ||||
| Senscure Biotechnology | Venture Capital-Backed | Ningbo, China | ||||
| Mölnlycke Health Care | Private Equity-Backed | Mölndal, Sweden |
CryoTherapeutics Patents
CryoTherapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2024285637-A1 | Refrigerant electromechanical control | Pending | 06-Jun-2023 | ||
| GB-202308402-D0 | Refrigerant electromechanical control | Pending | 06-Jun-2023 | ||
| GB-2630757-A | Refrigerant electromechanical control | Pending | 06-Jun-2023 | ||
| US-20260294502-A1 | Refrigerant electromechanical control | Pending | 06-Jun-2023 | ||
| WO-2024251912-A1 | Refrigerant electromechanical control | Inactive | 06-Jun-2023 | A61B18/02 |
CryoTherapeutics Signals
CryoTherapeutics Investors (13)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Buenavista Equity Partners Portugal | Asset Manager | Minority | ||
| Innomedical | Corporation | Minority | ||
| Yellowstone Holding | Venture Capital | Minority | ||
| Noshaq | Venture Capital | Minority | ||
| Walloon Region | Government |
CryoTherapeutics FAQs
-
When was CryoTherapeutics founded?
CryoTherapeutics was founded in 2009.
-
Where is CryoTherapeutics headquartered?
CryoTherapeutics is headquartered in Loncin, Belgium.
-
What is the size of CryoTherapeutics?
CryoTherapeutics has 12 total employees.
-
What industry is CryoTherapeutics in?
CryoTherapeutics’s primary industry is Therapeutic Devices.
-
Is CryoTherapeutics a private or public company?
CryoTherapeutics is a Private company.
-
What is CryoTherapeutics’s current revenue?
The current revenue for CryoTherapeutics is .
-
How much funding has CryoTherapeutics raised over time?
CryoTherapeutics has raised $58.8M.
-
Who are CryoTherapeutics’s investors?
Buenavista Equity Partners Portugal, Innomedical, Yellowstone Holding, Noshaq, and Walloon Region are 5 of 13 investors who have invested in CryoTherapeutics.
-
Who are CryoTherapeutics’s competitors?
Vygon (uk) Ltd., Tactile Medical, Senscure Biotechnology, and Mölnlycke Health Care are competitors of CryoTherapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process